The rising prevalence of cancer, cardiovascular diseases, and neurological diseases is expected to play a pivotal role in the growth of the resveratrol market in the coming years.Dallas, Texas, Jan. 26, 2021 (GLOBE NEWSWIRE) — The global resveratrol market is growing at a CAGR of 7.9% by 2028. An increase in prevalence of chronic disorders, surge in resveratrol supplements, and wide application areas of resveratrol are factors driving the global resveratrol market. Adroit Market Research report on global resveratrol market gives a holistic view of the market from 2018 to 2028, which includes factors such as market drivers, restraints, opportunities and challenges. The market has been studied for historic years from 2018 and 2019, with the base year of estimation as 2019 and forecast from 2020 to 2028. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the market based on Porter’s five forces analysis and positions the key players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global resveratrol market have been studied in detail. Request for a sample of this research report @ https://www.adroitmarketresearch.com/contacts/request-sample/503 Resveratrol is a natural stilbene and a non-flavonoid polyphenol, a phytoestrogen that predominates in antioxidant, anti-inflammatory, cardioprotective, and anti-cancer properties. It occurs naturally in many plants, such as grapes, and berries, and aids in assistance with respect to pathogenic infections. The first of its kind resveratrol was extracted from the root of a fast-growing shrub called the Japanese knotweed. Resveratrol is known to reverse multidrug resistance in cancer cells and is used in combination with drugs. Rapid rise in chronic ailments such as cancer, cardiac diseases, and neurological disorders will augment the demand for resveratrol products and supplements. However, side effects like gastrointestinal upset, headache, nausea and fatigue associated with resveratrol usage will hamper the growth of the market in the future. The global resveratrol market has been segmented based on product, application, form, distribution channel, and region. Based on product, the global resveratrol market is categorized into natural and synthetic resveratrol. Natural resveratrol segment is further sub-divided into grape seed extracted and knotweed extracted. Application-wise, the global resveratrol market is categorized into cosmetics, pharmaceuticals, dietary supplements and others. Cosmetics segment held substantial share of the market in 2019 owing to increase use of resveratrol in cosmetics owing to its anti-aging properties. Based on form, the global resveratrol market is classified as liquid, solid/powder and pill. Liquid resveratrol segment dominated the global market in 2019 owing to its ability to get quickly absorbed by the body and act as a free radical scavenger. The liquid form of resveratrol has naturally occurring proanthocyanidins (OPCs) from grape seed extract, VitaBerry, cranberry, and pomegranate, which complement resveratrol’s cellular and cardiovascular support properties. On the basis of distribution channel, the global resveratrol market is segmented into retail stores, online stores and others. Browse Complete Report with Table of Contents @ https://www.adroitmarketresearch.com/industry-reports/resveratrol-market North America dominated the global resveratrol market in 2019. High consumption of resveratrol supplements owing to its protective benefits for several health conditions across U.S. and Canada is a major factor for its dominant share. Asia Pacific is estimated to be the most lucrative market for resveratrol during the forecast period and is expected to grow at a faster pace from 2020 to 2028. Increasing demand from countries such as India and China and increasing awareness regarding the health benefits of resveratrol and high consumption in Asian countries such as Japan and China, as a traditional herbal remedy will drive the market in the region. Major players operating in the global resveratrol market include DSM, Evolva, Jeunesse Global, RevGenetics, Sabinsa Corporation, Maypro Industries, Hangzhou Great Forest Biomedical Ltd., Laurus Labs, Tianjin Jianfeng Natural Product R&D Co., Ltd., and Shanghai Natural Bio-engineering Co., Ltd. (Hunan Keyuan Bio-products Co., Ltd) among others. Based on segmentation global resveratrol market is fragmented into product, application, form, distribution channel and regional industry. By product, global resveratrol market is splintered into natural resveratrol, grape seed extracted, knotweed extracted & synthetic resveratrol. Based on application the market is classified into dietary supplements, cosmetics, pharmaceutical & others. Based on form the market is classified into liquid, solid/powder, pill. In terms of distribution channel, resveratrol market is segregated into retail stores, online stores & others. Further, resveratrol market is also fragmented on the basis of regional diversification, identifying Europe, North and South America, MEA and APAC as major growth spots in data science platform market. Direct purchase the report @ https://www.adroitmarketresearch.com/researchreport/purchase/503 Table of Content: 1. Introduction 2. Research Methodology 3. Market Outlook 4. Resveratrol Market by Product, 2018-2028 (USD Million) 5. Resveratrol Market by Application, 2018-2028 (USD Million) 6. Resveratrol Market by Form, 2018-2028 (USD Million) 7. Resveratrol Market by Distribution Channel, 2018-2028 (USD Million) 8. Resveratrol Market by Region, 2018-2028 (USD Million) 9. Company Profiles Browse Related Reports: Global Thoracic Drainage Devices Market Size 2019, by Product (Thoracic Drainage Systems, Thoracic Drainage Kits, Pleural Drainage Catheters, Trocar Drains, Others), by Application (Cardiac Surgery, Oncology & Pain Management, Thoracic Surgery & Pulmonology, General Intensive Care Emergency Medicine, Others), by Region and Forecast 2018 to 2028 Global Wound Debridement Market Size 2019, by Product (Gels, Ointment & creams, Surgical devices, Medical gauzes, Ultrasonic devices, Others), by Method (Autolytic, Enzymatic, Surgical, Mechanical, Others), by Wound Type (Pressure ulcers, Diabetic foot ulcers, Venous leg ulcers, Burn wound, Others), by Region and Forecast 2018 to 2028 Global Sternal Closure Systems Market Size 2020, By Product (Closure Devices, Bone Cement) Procedure (Median Sternotomy, Hemisternotomy, Bilateral Thoracosternotomy) Material (Stainless Steel, PEEK, Titanium) Region (North America, Europe, Asia Pacific, South America, Middle East and Africa) and Forecast 2021 to 2028 Access research repository of Upcoming Reports @ https://adroitmarketresearch.com/upcoming.html About Us: Adroit Market Research is a global business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps. Contact Us: Ryan Johnson Account Manager – Global 3131 McKinney Ave Ste 600 Dallas, TX 75204 Email ID: sales@adroitmarketresearch.com Phone No.: +1 972-362 -8199 Connect with us: Facebook | Twitter | LinkedIn
OTTAWA – Canada’s unemployment rate held steady at 6.5 per cent last month as hiring remained weak across the economy.
Statistics Canada’s labour force survey on Friday said employment rose by a modest 15,000 jobs in October.
Business, building and support services saw the largest gain in employment.
Meanwhile, finance, insurance, real estate, rental and leasing experienced the largest decline.
Many economists see weakness in the job market continuing in the short term, before the Bank of Canada’s interest rate cuts spark a rebound in economic growth next year.
Despite ongoing softness in the labour market, however, strong wage growth has raged on in Canada. Average hourly wages in October grew 4.9 per cent from a year ago, reaching $35.76.
Friday’s report also shed some light on the financial health of households.
According to the agency, 28.8 per cent of Canadians aged 15 or older were living in a household that had difficulty meeting financial needs – like food and housing – in the previous four weeks.
That was down from 33.1 per cent in October 2023 and 35.5 per cent in October 2022, but still above the 20.4 per cent figure recorded in October 2020.
People living in a rented home were more likely to report difficulty meeting financial needs, with nearly four in 10 reporting that was the case.
That compares with just under a quarter of those living in an owned home by a household member.
Immigrants were also more likely to report facing financial strain last month, with about four out of 10 immigrants who landed in the last year doing so.
That compares with about three in 10 more established immigrants and one in four of people born in Canada.
This report by The Canadian Press was first published Nov. 8, 2024.
The Canadian Institute for Health Information says health-care spending in Canada is projected to reach a new high in 2024.
The annual report released Thursday says total health spending is expected to hit $372 billion, or $9,054 per Canadian.
CIHI’s national analysis predicts expenditures will rise by 5.7 per cent in 2024, compared to 4.5 per cent in 2023 and 1.7 per cent in 2022.
This year’s health spending is estimated to represent 12.4 per cent of Canada’s gross domestic product. Excluding two years of the pandemic, it would be the highest ratio in the country’s history.
While it’s not unusual for health expenditures to outpace economic growth, the report says this could be the case for the next several years due to Canada’s growing population and its aging demographic.
Canada’s per capita spending on health care in 2022 was among the highest in the world, but still less than countries such as the United States and Sweden.
The report notes that the Canadian dental and pharmacare plans could push health-care spending even further as more people who previously couldn’t afford these services start using them.
This report by The Canadian Press was first published Nov. 7, 2024.
Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.
As Canadians wake up to news that Donald Trump will return to the White House, the president-elect’s protectionist stance is casting a spotlight on what effect his second term will have on Canada-U.S. economic ties.
Some Canadian business leaders have expressed worry over Trump’s promise to introduce a universal 10 per cent tariff on all American imports.
A Canadian Chamber of Commerce report released last month suggested those tariffs would shrink the Canadian economy, resulting in around $30 billion per year in economic costs.
More than 77 per cent of Canadian exports go to the U.S.
Canada’s manufacturing sector faces the biggest risk should Trump push forward on imposing broad tariffs, said Canadian Manufacturers and Exporters president and CEO Dennis Darby. He said the sector is the “most trade-exposed” within Canada.
“It’s in the U.S.’s best interest, it’s in our best interest, but most importantly for consumers across North America, that we’re able to trade goods, materials, ingredients, as we have under the trade agreements,” Darby said in an interview.
“It’s a more complex or complicated outcome than it would have been with the Democrats, but we’ve had to deal with this before and we’re going to do our best to deal with it again.”
American economists have also warned Trump’s plan could cause inflation and possibly a recession, which could have ripple effects in Canada.
It’s consumers who will ultimately feel the burden of any inflationary effect caused by broad tariffs, said Darby.
“A tariff tends to raise costs, and it ultimately raises prices, so that’s something that we have to be prepared for,” he said.
“It could tilt production mandates. A tariff makes goods more expensive, but on the same token, it also will make inputs for the U.S. more expensive.”
A report last month by TD economist Marc Ercolao said research shows a full-scale implementation of Trump’s tariff plan could lead to a near-five per cent reduction in Canadian export volumes to the U.S. by early-2027, relative to current baseline forecasts.
Retaliation by Canada would also increase costs for domestic producers, and push import volumes lower in the process.
“Slowing import activity mitigates some of the negative net trade impact on total GDP enough to avoid a technical recession, but still produces a period of extended stagnation through 2025 and 2026,” Ercolao said.
Since the Canada-United States-Mexico Agreement came into effect in 2020, trade between Canada and the U.S. has surged by 46 per cent, according to the Toronto Region Board of Trade.
With that deal is up for review in 2026, Canadian Chamber of Commerce president and CEO Candace Laing said the Canadian government “must collaborate effectively with the Trump administration to preserve and strengthen our bilateral economic partnership.”
“With an impressive $3.6 billion in daily trade, Canada and the United States are each other’s closest international partners. The secure and efficient flow of goods and people across our border … remains essential for the economies of both countries,” she said in a statement.
“By resisting tariffs and trade barriers that will only raise prices and hurt consumers in both countries, Canada and the United States can strengthen resilient cross-border supply chains that enhance our shared economic security.”
This report by The Canadian Press was first published Nov. 6, 2024.
